Invention Grant
- Patent Title: Pharmaceutical preparation comprising recombinant HcG
-
Application No.: US14283904Application Date: 2014-05-21
-
Publication No.: US09676835B2Publication Date: 2017-06-13
- Inventor: Ian Cottingham , Daniel Plaksin , Richard Boyd White
- Applicant: Ferring B.V.
- Applicant Address: NL Hoofddorp
- Assignee: Ferring B.V.
- Current Assignee: Ferring B.V.
- Current Assignee Address: NL Hoofddorp
- Agency: Fish & Richardson P.C.
- Priority: EP09252360 20091005
- Main IPC: C07K14/575
- IPC: C07K14/575 ; C12P21/00 ; C07K14/59 ; A61K38/16
Abstract:
The present disclosure describes recombinant human chorionic gonadotropin (hCG) and methods for the production thereof. The recombinant hCG can include α2,3, α2,6, and, optionally, α2,8 sialylation. The recombinant hCG can be produced in a human cell line such as a PER.C6® cell line.
Public/Granted literature
- US20140249082A1 Pharmaceutical Preparation Comprising Recombinant HcG Public/Granted day:2014-09-04
Information query
